To use or not to use: Clinical decision making in the face of uncertainty

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 3, 2011, Pages 284-285

  Rennard, Stephen I ^a   Vestbo, Jorgen ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUDESONIDE; PLACEBO;

ABNORMAL RESPIRATORY SOUND; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; EDITORIAL; FATIGUE; FEVER; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; PHARMACOEPIDEMIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOGRAPHY; RISK; THORAX RADIOGRAPHY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; DECISION MAKING; HUMANS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; UNCERTAINTY;

EID: 80051570396     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201104-0708ED     Document Type: Editorial

References (9)

1. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:2407-2416.
2. Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009;169:219-229.
3. Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007;176:162-166. (Pubitemid 47057852)
4. Chen D, Restrepo MI, Fine MJ, Pugh MJV, Anzueto A, Metersky ML, Nakashima B, Good C, Mortensen EM. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med 2011;184:312-316.
5. Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34:641-647.
6. Sin DD, Man SF. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:624-629. (Pubitemid 44411631)
7. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Yates JC, Jones PW. Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study. Clin Respir J 2011;5:44-49.
8. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S. (Pubitemid 30314474)
9. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-931. (Pubitemid 41598207)